Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication

Project Information

PRO-CF-MED

Grant agreement ID: 633545

DOI 10.3030/633545

Project closed

EC signature date 21 April 2015

Start date 1 May 2015

End date 31 December 2017

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 21 237 179,50

EU contribution € 5 997 139,00

Coordinated by

PROQR THERAPEUTICS NV
Netherlands